Adherium Launches Hailie Solution Direct-to-Consumer in the U.S. for Better Asthma and COPD Management

Adherium (ASX:ADR), a leading digital health platform that focuses on improving medication adherence and patient outcomes, today officially launched the...

Adherium Receives Additional U.S. FDA 510(k) Clearance for U.S. Consumer Launch of the Hailie™ Solution

Adherium (ASX:ADR) has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for over-the-counter sales of...